Mina Sooch

Company: Ocuphire

Job title: Chief Executive Officer

Seminars:

APX3330, An Oral Tablet for Treatment of Diabetic Retinopathy 5:30 pm

Ref-1, Novel target for retinal diseases Safety data across 11 Phase 1 and Phase 2 clinical trials Ongoing clinical trial designRead more

day: Day One

Panel Discussion: The Race to Market Share: Is the Answer Ending the Burden of Monthly Treatments? 4:10 pm

Longer-term VEGF inhibition is needed to combat the burden of monthly treatments. This panel will explore extended-duration therapeutic possibilities with a focus on the anti-VEGF pathway to reduce the number of times the patient has to visit the clinic and the side effects of the therapeutic. It will also touch on the question – is…Read more

day: Day One